Up to 50% of urethritis cases, the most common male reproductive tract syndrome, have no known etiology. Imbalances in the microbiota (dysbiosis) are increasingly recognized as factors in the development of clinical syndromes and may cause urethritis. In heterosexual men, Leptotrichia/Sneathia spp., were significantly associated with idiopathic non-gonococcal urethritis (NGU) and men with NGU had distinctive urethral microbial communities (e.g., lower species diversity and higher abundance of Lactobacillis iners and Gardnerella vaginalis than men without NGU), suggesting that the microbiota may play a causal role in the development of urethritis. However, the bacteria that characterized NGU in heterosexual men have been associated with female reproductive tract infection and are likely shared between sex partners. Men who have sex with men (MSM), who comprise half of NGU cases in many settings, rarely, if ever, have exposures to the vaginal microbiota. We hypothesize that the male urethral microbiota reflects the anatomic sites of exposure and that the nature of dysbiosis associated with NGU in MSM differs from heterosexual men. To test this, we will use broad range 16S rRNA gene PCR with high-throughput sequencing to (a) determine how the urethral microbiota that characterizes NGU in MSM differs from that in heterosexual men;(b) determine whether specific microbial communities are associated with persistence and recurrence of NGU in MSM after standard antibiotic therapy;and (c) explore the influence of specific sexual behaviors on the male urethral microbiota and recurrence of NGU. These studies will enhance the clinical management of NGU in the group at highest risk of sexually transmitted infection and HIV, and may lead to novel prevention strategies and/or clinical trials of new therapies to eradicate key bacterial species or restore normal bacteria.
The majority of non-gonococcal urethritis (NGU) cases have no identified etiology and half occur in men who have sex with men (MSM), the group at highest risk of sexually transmitted infection and HIV. This proposed study will define urethral microbiota associated with NGU in MSM, identify distinct microbiota that predict persistence and recurrence of NGU, and determine which exposures perturb the normal urethral microbiota.
|Khosropour, Christine M; Dombrowski, Julia C (2018) A Web of Complexity: Untangling the Routes of Rectal Chlamydia Acquisition. Sex Transm Dis 45:511-513|
|Fink, Susan L; Vojtech, Lucia; Wagoner, Jessica et al. (2018) The Antiviral Drug Arbidol Inhibits Zika Virus. Sci Rep 8:8989|
|Reeves, Daniel B; Duke, Elizabeth R; Wagner, Thor A et al. (2018) A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nat Commun 9:4811|
|Khosropour, Christine M; Bell, Teal R; Hughes, James P et al. (2018) A Population-Based Study to Compare Treatment Outcomes Among Women With Urogenital Chlamydial Infection in Washington State, 1992 to 2015. Sex Transm Dis 45:319-324|
|Balle, Christina; Lennard, Katie; Dabee, Smritee et al. (2018) Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection. Sci Rep 8:11109|
|Gasper, Melanie A; Hesseling, Anneke C; Mohar, Isaac et al. (2017) BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial. JCI Insight 2:e91963|
|Manhart, Lisa E (2017) Mycoplasma genitalium on the Loose: Time to Sound the Alarm. Sex Transm Dis 44:463-465|
|Herbst-Kralovetz, Melissa M; Pyles, Richard B; Ratner, Adam J et al. (2016) New Systems for Studying Intercellular Interactions in Bacterial Vaginosis. J Infect Dis 214 Suppl 1:S6-S13|
|Gasper, Melanie A; Biswas, Shameek P; Fisher, Bridget S et al. (2016) Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG. PLoS One 11:e0158149|
|Mayer, Bryan T; Srinivasan, Sujatha; Fiedler, Tina L et al. (2015) Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. J Infect Dis 212:793-802|
Showing the most recent 10 out of 12 publications